Drug Approval | May 06, 2024
Briefs: Eugia Pharma Specialities and IOL Chemicals and Pharmaceuticals
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements
This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.
The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence
The company has already embarked upon significant expansion in Turkey
The GMP certificate is valid for three years until April 2024.
Lasa Supergenerics Limited has received WHO GMP Certificate for its manufacturing facility situated at Khed in Ratnagiri.
Subscribe To Our Newsletter & Stay Updated
